PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

B-RAF Inhibitor Dabrafenib Attenuates RIPK3-Mediated Necroptosis and Promotes Functional Recovery after Spinal Cord Injury.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31817643 ↗2019Reported benefit

B-RAF Inhibitor Dabrafenib Attenuates RIPK3-Mediated Necroptosis and Promotes Functional Recovery after Spinal Cord Injury.

MouseSpinal cord injuryContusionC57BL/6Jfemalen = 12 per group in the locomotor cohort; other per-group n not…Oral gavage100 mg/kg in 200 microlitres of 0.5 per cent hydroxypropyl…4, 24 and 48 hours after injury

Model: Thoracic (T10) contusion spinal cord injury using a modified MASCIS impactor, 10 g rod with 1.5 mm tip dropped from 3 mm

Acute oral dabrafenib reduced RIPK3 and phospho-MLKL expression and necrotic cell numbers, preserved white matter, neurons and axons, shortened motor evoked potential latency and improved locomotor and sensory recovery versus vehicle.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.